|
|
9/3/2003 9:15:31 AM ET
SWISS MEDICA AWARDS NORTH AMERICAN LAUNCH OF O24 TO HOLMES & LEE
FOR IMMEDIATE RELEASE
Stock Symbol: OTC BB:SWME
September 3, 2003
SWISS MEDICA AWARDS NORTH AMERICAN LAUNCH OF O24 TO HOLMES & LEE
Toronto, Canada – Swiss Medica Inc. has awarded the launch of its 024 Pain Relief product to Holmes & Lee -
Advertising, Design & Interactive, of Toronto, Ontario.
Swiss Medica is focused on acquiring over-the-counter bioscience products with demonstrable competitive
advantages, subsequently launching them with full communications efforts, including advertising, direct sales,
interactive, multi-level marketing and e-commerce.
024 is a patented, natural essential oil pain relief product first introduced in Europe for application in the sports,
hospital and medical communities.
"We intend to launch throughout North America this fall with a mainstream consumer effort through multiple
channels" stated Raghu Kilambi, Chairman and CEO of Swiss Medica Inc. "Holmes & Lee have a proven history
in providing strong, blue chip brands like Second Cup Coffee Company, Canada Trust, Sears Canada and Land
Rover with exceptional creative work. We were particularly impressed with their experience in providing
successful sales positions for OTC products like Clearblue Easy, Nettlemax and Delsym Cough Remedy with
impactful communications efforts."
Holmes & Lee will provide an evolved identity for 024, from logo and package design, to television advertising
and promotion, to interactive support.
"It is rare that we get a chance to become deeply involved with a product so early in the game - especially a
product that we absolutely believe is a 'category killer'" said John Lee, President of Holmes & Lee. "It is an
excellent opportunity, and we are very excited at the 024 potential in North America."
About Swiss Medica Inc.
Swiss Medica Inc. is focused on acquiring over-the-counter bioscience products with demonstrated competitive
advantages and increasing their revenues by focused sales and marketing efforts in selected distribution
channels including retail, direct sales, direct response, and e-commerce. Swiss Medica’s mission is to be a world
leader in the acquisition and commercialization of life enhancing bioscience products that improve quality of
lives. Please visit our website at www.swissmedica.com
About Holmes & Lee
Holmes & Lee is a company with a simple mission. Make their clients brands best of category". The company has
successfully achieved this mission with fully integrated and orchestrated campaigns for their clients in the retail,
packaged goods, automotive, fashion, tourism, alcohol beverages, food, pharmaceutical, institutional and media
areas.
With founding partners Peter Holmes and John Lee in the lead, Holmes & Lee provide a strong strategic and
creative product that has provided both great results and industry acknowledgment for their clients.
www.holmesandlee.com
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the
United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
transactions being contemplated, risks related to international sales and potential foreign currency exchange
fluctuations, continued acceptance of Swiss Medica’s services, increased levels of competition, technological
changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica’s
periodic reports filed with the United States Securities and Exchange Commission and other regulatory
authorities.
Investor Relations Contact:
Dave Jones: 705 495 0022
djones@swissmedica.com
|
|
